ゲノミクス市場：オファリング、技術、タイプ、用途、エンドユーザー別-2025～2030年世界予測

ゲノミクス市場の2024年の市場規模は522億2,000万米ドルで、2025年には571億5,000万米ドル、CAGR 9.78%で成長し、2030年には914億5,000万米ドルに達すると予測されています。

近年、ゲノミクス産業は、画期的な技術の進歩や、健康と疾病の両方を促進する遺伝的メカニズムの深化に後押しされ、著しい進化を遂げています。革新的な手法と新しい機器の急速な統合は、研究パラダイムのみならず臨床応用をも再定義しています。本書はゲノミクスエコシステム洞察に満ちた概要を提供し、市場力学、セグメンテーション、地域的影響、このセグメントで新たなベンチマークを設定しつつある主要企業について詳述します。

研究と商業的利益の継続的な相互作用により、発見のペースが加速しています。産業の利害関係者は、個別化医療、作物開発、創薬に新たな道を開く伝統的技術と急進的な革新の岐路に立たされていることに気づいています。ゲノム研究の進化は、治療法の進歩とともに診断法の改良にも貢献し、最終的には商業化の機会を拡大しながら患者ケアを変革しています。研究機関、病院、製薬・バイオテクノロジー関連企業がこれらの進歩を統合するにつれ、このような変革的イノベーションの影響はますます目に見えるものとなっています。

さらに、市場の力と消費者の需要との相互作用が、技術とインフラの両方への投資を刺激しています。最先端のシークエンシング技術と先進的バイオインフォマティクスを活用することで、組織はより正確で効率的な治療への道を切り開いてきました。急速な開発を特徴とするこの状況は、科学的ブレークスルーと戦略的イニシアチブの合流によって、大きな成長を約束するものです。以下では、このような産業のシフトの主要な側面、セグメンテーションの詳細な洞察、世界のゲノム動向の微妙な視点を提供する地域差について概説します。

ゲノミクスに影響を与える変革的変化

ゲノミクス市場における最近の変革的シフトは、技術的躍進、進化する規制状況、利害関係者の優先事項の変化を反映しています。自動化、小型化、統合データ分析の進歩は、ラボのワークフローと業務効率を再構築しました。シーケンス技術と装置の新たな開発により、以前には想像もできなかったレベルの精度と拡大性が可能になりました。

次世代シーケンスプラットフォーム、デジタルPCRの強化、マルチプレキシング機能の拡大などの技術革新は総体的に、スピード、正確性、費用対効果が譲れないパラダイムに貢献しています。これは研究開発への投資によって補完され、バイオインフォマティクスとウェットラボプロセスの融合を推進し続けています。サンプル調製の改善と高性能分析法により、ラボは現在、複雑な遺伝子変異やエピジェネティック修飾を驚くほど明瞭に明らかにすることができます。

さらに、規制施策の進化と官民の協力体制の強化は、製品開発の合理化と臨床検査の迅速化に極めて重要な役割を果たしています。このような協力関係は、資金調達の強化、戦略的パートナーシップ、ゲノミクスの未来はイノベーション主導の患者中心のソリューションにかかっているという利害関係者間のビジョン共有につながっています。膨大なデータセットを処理するための人工知能と機械学習の統合もまた、診断法の改良と標的治療法の開発における重要な要因として浮上しています。

全体として、このような変革的なシフトは、多角的な研究が実用的な用途に融合する新たな領域へとゲノム産業を押し進めつつあります。技術革新のペースは加速し続けており、ゲノミクスの科学とビジネスの両方を再定義する有望な未来を示唆しています。

ゲノム市場の詳細なセグメンテーション洞察

ゲノミクス市場のセグメンテーション分析により、多様な製品、技術、分析タイプ、用途、ユーザー層を多層的に理解することができます。市場の包括的な調査は、オファリング、技術、タイプ、用途、エンドユーザーに基づいてセグメント化されます。例えば、オファリングのカテゴリーでは、市場は消耗品、機器、サービスに区分されます。消耗品では、さらにキットとアッセイ、試薬に区別し、機器ではアナライザとシーケンサーに分類しています。この構造により、製品の差別化が明確になるだけでなく、市場内の明確な収益の流れが浮き彫りになります。

技術的セグメンテーションについては、遺伝子編集技術、マイクロアレイ技術、PCR技術、シーケンス技術の進化に焦点を移しています。遺伝子編集技術はCRISPR/Cas9、TALEN、ジンクフィンガーヌクレアーゼに関して評価され、マイクロアレイ技術は細胞マイクロアレイ、DNAマイクロアレイ、タンパク質マイクロアレイを調査することで改良され、PCR技術はデジタルPCR、エンドポイントPCR、リアルタイムPCRに分解され、シークエンシング技術は次世代、サンガー、第3世代のシークエンシング法にまたがる厳密な分析を受けています。このような差別化は、成長セグメント、潜在的投資対象、研究動向の特定において産業リーダーを支援します。

ゲノム分析タイプによる別セグメンテーションには、エピゲノミクス、機能ゲノミクス、薬理ゲノミクス、構造ゲノミクスが含まれます。この分類は、特定の科学的・臨床的目標と市場の提供物を整合させ、研究の焦点と資源配分を最適化する上で極めて重要です。さらに、用途ベースのセグメンテーションは、動物遺伝学、農作物開発、診断学、創薬・開発、個別化医療、研究開発に及びます。各用途は独自の課題と機会を提供し、技術の進歩が大きな成果をもたらす可能性が最も高いニッチセグメントについて洞察を与えます。

最後に、エンドユーザーによるセグメンテーションでは、農業関連企業、病院クリニック、製薬・バイオテクノロジー企業、研究機関における市場展開の詳細な展望を記載しています。畜産会社と種苗会社にさらに細分化された農業関連事業セグメントは、農業遺伝学と作物開拓における特殊な要件と独自の市場力学を強調しています。このように構造化されたセグメンテーションは、現在の市場動向の理解を深めるだけでなく、利害関係者がそれぞれの事業セグメントに特化した戦略を立てることを可能にします。

これらのセグメント化された洞察は、戦略立案と投資決定のための強力な基盤となります。各セグメントがそれぞれ独自の機会と課題を提示する中、包括的な分析は、ますますダイナミックになる市場の複雑さを乗り切るためのロードマップとして役立ちます。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界的に遺伝性疾患の有病率が増加
    • 精密医療と個別化治療への移行の拡大
    • 農業と法医学におけるゲノミクスの応用拡大
  • 抑制要因
    • 検査で使用される遺伝的多様性の評価に関連する懸念
  • 機会
    • AIと先進的バイオインフォマティクスの統合によるゲノムデータ分析の自動化と強化
    • 政府と民間組織によるゲノミクスの研究開発への資金と助成金の増加
  • 課題
    • 標準化された方法論の欠如により、ゲノミクスフィールドの実装の効率が低下
• 市場セグメンテーション分析
  • オファリング：遺伝性疾患の診断と理解のためのゲノミクスにおける分析装置の意義の向上
  • 技術：精度、効率、汎用性によりCRISPR/Cas9の応用範囲を拡大
  • タイプ：遺伝子構成間の複雑な関係を決定するための機能的ゲノミクスの利点の増加
  • 用途：動物遺伝学における病気抵抗性と活力のためのゲノミクスの採用拡大
  • エンドユーザー：種子会社による高収量作物品種の開発におけるゲノミクスの新たな導入
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 ゲノミクス市場：オファリング別

• イントロダクション
• 消耗品
  • キットとアッセイ
  • 試薬
• 機器
  • アナライザ
  • シーケンサー
• サービス

第7章 ゲノミクス市場：技術別

• イントロダクション
• 遺伝子編集技術
  • CRISPR/Cas9
  • TALENs
  • ジンクフィンガーヌクレアーゼ
• マイクロアレイ技術
  • 細胞マイクロアレイ
  • DNAマイクロアレイ
  • タンパク質マイクロアレイ
• PCR技術
  • デジタルPCR
  • エンドポイントPCR
  • リアルタイムPCR
• シーケンス技術
  • 次世代シーケンス
  • サンガーシーケンス
  • 第三世代シーケンス

第8章 ゲノミクス市場：タイプ別

• イントロダクション
• エピゲノミクス
• 機能ゲノミクス
• 薬理ゲノミクス
• 構造ゲノミクス

第9章 ゲノミクス市場：用途別

• イントロダクション
• 動物遺伝学
• 作物の開発
• 診断
• 医薬品の発見と開発
• パーソナライズ医療
• 研究開発

第10章 ゲノミクス市場：エンドユーザー別

• イントロダクション
• 農業ビジネス
  • 畜産会社
  • 種子会社
• 病院とクリニック
• 製薬・バイオテクノロジー企業
• 研究機関

第11章 南北アメリカのゲノミクス市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋のゲノミクス市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカのゲノミクス市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析、2024年
• FPNVポジショニングマトリックス、2024年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 10x Genomics, Inc.
• 23andMe Holding Co.
• Agilent Technologies, Inc.
• BGI Genomics Co., Ltd.
• Bio-Rad Laboratories, Inc.
• Centogene N.V.
• EPIC Sciences, Inc.
• Eurofins Scientific SE
• F. Hoffmann-La Roche Ltd.
• GE Healthcare（Now Cytiva）by Danaher Corporation
• Gencove, Inc.
• GenScript BIoTech Corporation
• Guardant Health, Inc.
• Helix OpCo, LLC
• Illumina, Inc.
• Invitae Corporation
• Merck & Co., Inc.
• Myriad Genetics Laboratories, Inc.
• Natera, Inc.
• Oxford Nanopore Technologies PLC
• Pacific Biosciences of California, Inc.
• Personalis, Inc.
• Quest Diagnostics
• SomaLogic, Inc.
• Sophia Genetics SA
• Thermo Fisher Scientific Inc.
• Twist Bioscience Corporation

LIST OF FIGURES

• FIGURE 1. GENOMICS MARKET MULTI-CURRENCY
• FIGURE 2. GENOMICS MARKET MULTI-LANGUAGE
• FIGURE 3. GENOMICS MARKET RESEARCH PROCESS
• FIGURE 4. GENOMICS MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL GENOMICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL GENOMICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL GENOMICS MARKET SIZE, BY OFFERING, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL GENOMICS MARKET SIZE, BY OFFERING, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL GENOMICS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL GENOMICS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL GENOMICS MARKET SIZE, BY APPLICATIONS, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL GENOMICS MARKET SIZE, BY APPLICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL GENOMICS MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
• FIGURE 17. GLOBAL GENOMICS MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. AMERICAS GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 19. AMERICAS GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. UNITED STATES GENOMICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 21. UNITED STATES GENOMICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 26. GENOMICS MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 27. GENOMICS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. GENOMICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL GENOMICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL GENOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. GENOMICS MARKET DYNAMICS
• TABLE 7. GLOBAL GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL GENOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL GENOMICS MARKET SIZE, BY KITS & ASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL GENOMICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL GENOMICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL GENOMICS MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL GENOMICS MARKET SIZE, BY SEQUENCERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL GENOMICS MARKET SIZE, BY SERVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL GENOMICS MARKET SIZE, BY CRISPR/CAS9, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL GENOMICS MARKET SIZE, BY TALENS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL GENOMICS MARKET SIZE, BY ZINC FINGER NUCLEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL GENOMICS MARKET SIZE, BY CELLULAR MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL GENOMICS MARKET SIZE, BY DNA MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL GENOMICS MARKET SIZE, BY PROTEIN MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL GENOMICS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL GENOMICS MARKET SIZE, BY END-POINT PCR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL GENOMICS MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL GENOMICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL GENOMICS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL GENOMICS MARKET SIZE, BY THIRD-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL GENOMICS MARKET SIZE, BY EPIGENOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL GENOMICS MARKET SIZE, BY FUNCTIONAL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL GENOMICS MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL GENOMICS MARKET SIZE, BY STRUCTURAL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL GENOMICS MARKET SIZE, BY ANIMAL GENETICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL GENOMICS MARKET SIZE, BY CROP DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 46. GLOBAL GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 47. GLOBAL GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 48. GLOBAL GENOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 49. GLOBAL GENOMICS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 50. GLOBAL GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 51. GLOBAL GENOMICS MARKET SIZE, BY AGRIBUSINESS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 52. GLOBAL GENOMICS MARKET SIZE, BY LIVESTOCK COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 53. GLOBAL GENOMICS MARKET SIZE, BY SEED COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 54. GLOBAL GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
• TABLE 55. GLOBAL GENOMICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 56. GLOBAL GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 57. GLOBAL GENOMICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 58. AMERICAS GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 59. AMERICAS GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 60. AMERICAS GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 61. AMERICAS GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 62. AMERICAS GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 63. AMERICAS GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 64. AMERICAS GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. AMERICAS GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 66. AMERICAS GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. AMERICAS GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 68. AMERICAS GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 69. AMERICAS GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
• TABLE 70. AMERICAS GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 71. ARGENTINA GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 72. ARGENTINA GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 73. ARGENTINA GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 74. ARGENTINA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. ARGENTINA GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 76. ARGENTINA GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 77. ARGENTINA GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 78. ARGENTINA GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 79. ARGENTINA GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. ARGENTINA GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 81. ARGENTINA GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 82. ARGENTINA GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
• TABLE 83. BRAZIL GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 84. BRAZIL GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 85. BRAZIL GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 86. BRAZIL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 87. BRAZIL GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 88. BRAZIL GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 89. BRAZIL GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 90. BRAZIL GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. BRAZIL GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. BRAZIL GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 93. BRAZIL GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 94. BRAZIL GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
• TABLE 95. CANADA GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 96. CANADA GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 97. CANADA GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 98. CANADA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 99. CANADA GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 100. CANADA GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 101. CANADA GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 102. CANADA GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 103. CANADA GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. CANADA GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 105. CANADA GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 106. CANADA GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
• TABLE 107. MEXICO GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 108. MEXICO GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 109. MEXICO GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 110. MEXICO GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 111. MEXICO GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 112. MEXICO GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 113. MEXICO GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 114. MEXICO GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 115. MEXICO GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. MEXICO GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 117. MEXICO GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 118. MEXICO GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
• TABLE 119. UNITED STATES GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 120. UNITED STATES GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 121. UNITED STATES GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 122. UNITED STATES GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 123. UNITED STATES GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 124. UNITED STATES GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 125. UNITED STATES GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 126. UNITED STATES GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 127. UNITED STATES GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. UNITED STATES GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 129. UNITED STATES GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 130. UNITED STATES GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
• TABLE 131. UNITED STATES GENOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 132. ASIA-PACIFIC GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 133. ASIA-PACIFIC GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 134. ASIA-PACIFIC GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 135. ASIA-PACIFIC GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 136. ASIA-PACIFIC GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 137. ASIA-PACIFIC GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 138. ASIA-PACIFIC GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 139. ASIA-PACIFIC GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 140. ASIA-PACIFIC GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. ASIA-PACIFIC GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 142. ASIA-PACIFIC GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 143. ASIA-PACIFIC GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
• TABLE 144. ASIA-PACIFIC GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 145. AUSTRALIA GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 146. AUSTRALIA GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 147. AUSTRALIA GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 148. AUSTRALIA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 149. AUSTRALIA GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 150. AUSTRALIA GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 151. AUSTRALIA GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 152. AUSTRALIA GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 153. AUSTRALIA GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 154. AUSTRALIA GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 155. AUSTRALIA GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 156. AUSTRALIA GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
• TABLE 157. CHINA GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 158. CHINA GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 159. CHINA GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 160. CHINA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 161. CHINA GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 162. CHINA GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 163. CHINA GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 164. CHINA GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 165. CHINA GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 166. CHINA GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 167. CHINA GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 168. CHINA GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
• TABLE 169. INDIA GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 170. INDIA GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 171. INDIA GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 172. INDIA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 173. INDIA GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 174. INDIA GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 175. INDIA GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 176. INDIA GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 177. INDIA GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 178. INDIA GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 179. INDIA GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 180. INDIA GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
• TABLE 181. INDONESIA GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 182. INDONESIA GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 183. INDONESIA GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 184. INDONESIA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 185. INDONESIA GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 186. INDONESIA GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 187. INDONESIA GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 188. INDONESIA GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 189. INDONESIA GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 190. INDONESIA GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 191. INDONESIA GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 192. INDONESIA GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
• TABLE 193. JAPAN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 194. JAPAN GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 195. JAPAN GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 196. JAPAN GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 197. JAPAN GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 198. JAPAN GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 199. JAPAN GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 200. JAPAN GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 201. JAPAN GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 202. JAPAN GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 203. JAPAN GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 204. JAPAN GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
• TABLE 205. MALAYSIA GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 206. MALAYSIA GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 207. MALAYSIA GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 208. MALAYSIA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 209. MALAYSIA GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 210. MALAYSIA GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 211. MALAYSIA GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 212. MALAYSIA GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 213. MALAYSIA GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 214. MALAYSIA GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 215. MALAYSIA GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 216. MALAYSIA GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
• TABLE 217. PHILIPPINES GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 218. PHILIPPINES GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 219. PHILIPPINES GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 220. PHILIPPINES GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 221. PHILIPPINES GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 222. PHILIPPINES GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 223. PHILIPPINES GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 224. PHILIPPINES GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 225. PHILIPPINES GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 226. PHILIPPINES GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 227. PHILIPPINES GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 228. PHILIPPINES GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
• TABLE 229. SINGAPORE GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 230. SINGAPORE GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 231. SINGAPORE GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 232. SINGAPORE GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 233. SINGAPORE GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 234. SINGAPORE GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 235. SINGAPORE GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 236. SINGAPORE GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 237. SINGAPORE GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 238. SINGAPORE GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 239. SINGAPORE GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 240. SINGAPORE GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH KOREA GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH KOREA GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH KOREA GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 244. SOUTH KOREA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 245. SOUTH KOREA GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 246. SOUTH KOREA GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 247. SOUTH KOREA GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 248. SOUTH KOREA GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 249. SOUTH KOREA GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 250. SOUTH KOREA GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 251. SOUTH KOREA GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 252. SOUTH KOREA GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
• TABLE 253. TAIWAN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 254. TAIWAN GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 255. TAIWAN GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 256. TAIWAN GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 257. TAIWAN GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 258. TAIWAN GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 259. TAIWAN GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 260. TAIWAN GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 261. TAIWAN GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 262. TAIWAN GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 263. TAIWAN GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 264. TAIWAN GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
• TABLE 265. THAILAND GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 266. THAILAND GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 267. THAILAND GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 268. THAILAND GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 269. THAILAND GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 270. THAILAND GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 271. THAILAND GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 272. THAILAND GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 273. THAILAND GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 274. THAILAND GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 275. THAILAND GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 276. THAILAND GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
• TABLE 277. VIETNAM GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 278. VIETNAM GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 279. VIETNAM GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 280. VIETNAM GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 281. VIETNAM GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 282. VIETNAM GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 283. VIETNAM GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 284. VIETNAM GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 285. VIETNAM GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 286. VIETNAM GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 287. VIETNAM GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 288. VIETNAM GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
• TABLE 289. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 290. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 291. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 292. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 293. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 294. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 295. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 296. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 297. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 298. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 299. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 300. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
• TABLE 301. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 302. DENMARK GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 303. DENMARK GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 304. DENMARK GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 305. DENMARK GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 306. DENMARK GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 307. DENMARK GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 308. DENMARK GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 309. DENMARK GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 310. DENMARK GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 311. DENMARK GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 312. DENMARK GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 313. DENMARK GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
• TABLE 314. EGYPT GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 315. EGYPT GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 316. EGYPT GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 317. EGYPT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 318. EGYPT GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 319. EGYPT GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 320. EGYPT GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 321. EGYPT GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 322. EGYPT GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 323. EGYPT GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 324. EGYPT GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 325. EGYPT GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
• TABLE 326. FINLAND GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 327. FINLAND GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 328. FINLAND GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 329. FINLAND GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 330. FINLAND GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 331. FINLAND GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 332. FINLAND GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 333. FINLAND GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 334. FINLAND GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 335. FINLAND GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 336. FINLAND GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 337. FINLAND GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
• TABLE 338. FRANCE GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 339. FRANCE GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 340. FRANCE GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 341. FRANCE GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 342. FRANCE GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 343. FRANCE GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 344. FRANCE GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 345. FRANCE GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 346. FRANCE GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 347. FRANCE GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 348. FRANCE GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 349. FRANCE GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
• TABLE 350. GERMANY GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 351. GERMANY GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 352. GERMANY GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 353. GERMANY GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 354. GERMANY GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 355. GERMANY GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 356. GERMANY GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 357. GERMANY GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 358. GERMANY GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 359. GERMANY GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 360. GERMANY GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 361. GERMANY GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
• TABLE 362. ISRAEL GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 363. ISRAEL GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 364. ISRAEL GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 365. ISRAEL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 366. ISRAEL GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 367. ISRAEL GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 368. ISRAEL GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 369. ISRAEL GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 370. ISRAEL GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 371. ISRAEL GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 372. ISRAEL GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 373. ISRAEL GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
• TABLE 374. ITALY GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 375. ITALY GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 376. ITALY GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 377. ITALY GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 378. ITALY GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 379. ITALY GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 380. ITALY GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 381. ITALY GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 382. ITALY GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 383. ITALY GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 384. ITALY GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 385. ITALY GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
• TABLE 386. NETHERLANDS GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 387. NETHERLANDS GENOMICS MARKET SIZE, BY CONSUMABLES,

The Genomics Market was valued at USD 52.22 billion in 2024 and is projected to grow to USD 57.15 billion in 2025, with a CAGR of 9.78%, reaching USD 91.45 billion by 2030.

In recent years, the genomics industry has undergone a significant evolution fueled by groundbreaking technological advancements and a deepening understanding of genetic mechanisms that drive both health and disease. The rapid integration of innovative methodologies and novel instrumentation has redefined not only research paradigms but also clinical applications. This document provides an insightful overview of the genomics ecosystem, detailing market dynamics, segmentation, regional influences, and the leading companies that are setting new benchmarks in the field.

The continuous interplay of research and commercial interests has accelerated the pace of discovery. Industry stakeholders are finding themselves at the crossroads of traditional techniques and radical innovations that open new avenues for personalized medicine, crop development, and drug discovery. The evolution of genomic research has also contributed to the refinement of diagnostics alongside therapeutic advancements, ultimately transforming patient care while expanding the opportunities for commercialization. As research institutions, hospitals, and companies engaged in pharmaceutical and biotechnology integrate these advancements, the impact of such transformative innovations is increasingly visible.

Furthermore, the interplay between market forces and consumer demand has stimulated investments in both technology and infrastructure. By harnessing state-of-the-art sequencing techniques and advanced bioinformatics, organizations have paved the way for more precise and efficient therapies. This landscape, marked by rapid development, promises substantial growth driven by a confluence of scientific breakthroughs and strategic initiatives. The narrative that follows outlines key aspects of these industry shifts, detailed segmentation insights, and the regional variations that provide a nuanced perspective on global genomics trends.

Transformative Changes Impacting Genomics

Recent transformative shifts in the genomics market reflect a convergence of technological breakthroughs, evolving regulatory landscapes, and shifting stakeholder priorities. Advancements in automation, miniaturization, and integrated data analytics have reimagined laboratory workflows and operational efficiencies. New developments in sequencing technologies and instrumentation have enabled a level of precision and scalability that was previously unimaginable.

Technological innovations such as next-generation sequencing platforms, digital PCR enhancements, and extended multiplexing capabilities have collectively contributed to a paradigm where speed, accuracy, and cost-effectiveness are non-negotiable. This is complemented by investments in research and development, which continue to drive the convergence of bioinformatics with wet-lab processes. With improved sample preparations and high-throughput analytical methods, laboratories can now uncover complex genetic variations and epigenetic modifications with remarkable clarity.

Further, evolving regulatory policies and increased collaboration across public and private sectors have played a pivotal role in streamlining product development and expediting clinical trials. Such collaboration has led to enhanced funding, strategic partnerships, and a shared vision among stakeholders that the future of genomics rests on innovation-driven, patient-centric solutions. The integration of artificial intelligence and machine learning to process massive data sets has also emerged as a key factor in refining diagnostics and developing targeted therapies.

Overall, these transformative shifts are pushing the genomics industry into new realms where multidimensional research converges with practical applications. The pace of innovation continues to accelerate, signaling a promising future that redefines both the science and business of genomics.

Detailed Segmentation Insights in Genomics Market

The segmentation analysis of the genomics market provides a multilayered understanding of diverse offerings, technologies, analytical types, applications, and user demographics. A comprehensive study of the market is segmented based on offering, technology, type, applications, and end users. For instance, in the offering category, the market is segmented into consumables, instruments, and service. Within consumables, the analysis further distinguishes between kits and assays and reagents, while instruments are reviewed through the lens of analyzers and sequencers. This structure not only clarifies product differentiation but also highlights distinct revenue streams within the market.

Regarding technological segmentation, the focus shifts to the evolution of gene editing techniques, microarray technology, PCR technology, and sequencing technology. Each of these sub-segments is dissected to reveal further insights: gene editing techniques are evaluated with respect to CRISPR/Cas9, TALENs, and zinc finger nucleases; microarray technology is refined by exploring cellular microarray, DNA microarray, and protein microarray; PCR technology is dissected into digital PCR, end-point PCR, and real-time PCR; sequencing technology undergoes rigorous analysis spanning next-generation, Sanger, and third-generation sequencing methods. Such differentiation assists industry leaders in identifying growth areas, potential investment targets, and research trends.

A separate segmentation based on the type of genomic analysis encompasses epigenomics, functional genomics, pharmacogenomics, and structural genomics. This categorization is critical in aligning market offerings with specific scientific and clinical goals, hence optimizing research focus and resource allocation. Moreover, application-based segmentation spans animal genetics, crop development, diagnostics, drug discovery and development, personalized medicine, and research and development. Each application provides unique challenges and opportunities, giving insight into niches where technological advancement is most likely to yield significant results.

Finally, the segmentation based on end users offers a detailed perspective on market deployment across agribusiness, hospitals and clinics, pharmaceutical and biotechnology companies, and research institutes. The agribusiness segment, further delineated into livestock companies and seed companies, underscores the specialized requirements and unique market dynamics in agricultural genetics and crop development. This structured segmentation not only enriches the understanding of current market trends but also enables stakeholders to tailor strategies specifically to their area of operation.

Taken together, these segmented insights provide a strong foundation for strategic planning and investment decisions. With each segment presenting its own set of opportunities and challenges, the comprehensive analysis serves as a roadmap for navigating the complexities of an increasingly dynamic market.

Based on Offering, market is studied across Consumables, Instruments, and Service. The Consumables is further studied across Kits & Assays and Reagents. The Instruments is further studied across Analyzers and Sequencers.

Based on Technology, market is studied across Gene Editing Technique, Microarray Technology, PCR Technology, and Sequencing Technology. The Gene Editing Technique is further studied across CRISPR/Cas9, TALENs, and Zinc Finger Nucleases. The Microarray Technology is further studied across Cellular Microarray, DNA Microarray, and Protein Microarray. The PCR Technology is further studied across Digital PCR, End-Point PCR, and Real-Time PCR. The Sequencing Technology is further studied across Next-Generation Sequencing, Sanger Sequencing, and Third-Generation Sequencing.

Based on Type, market is studied across Epigenomics, Functional Genomics, Pharmacogenomics, and Structural Genomics.

Based on Applications, market is studied across Animal Genetics, Crop Development, Diagnostics, Drug Discovery & Development, Personalized Medicine, and Research & Development.

Based on End Users, market is studied across Agribusiness, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Research Institutes. The Agribusiness is further studied across Livestock Companies and Seed Companies.

Regional Market Dynamics in a Global Perspective

Global analysis of the genomics market reveals significant regional variations that underline the international pace of innovation and investment. The dynamics in the Americas are marked by advanced research infrastructure, strong investment in biotechnology, and a robust clinical application environment. In contrast, the landscape in Europe, the Middle East, and Africa exhibits rapid adjustments to technological advancements with rising public-private collaborations. Asia-Pacific, meanwhile, continues to demonstrate impressive growth spearheaded by large-scale government initiatives and rapid industrialization, driving innovation and competitive pricing across the market.

These regional insights highlight that while technological and research advancements serve as universal catalysts, local policy frameworks, funding mechanisms, and market readiness differ greatly. Consequently, each region presents unique investment opportunities and specific challenges tailored to their economic and regulatory contexts.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Leading Companies Driving Genomics Innovation

The competitive landscape is characterized by a plethora of key companies that are at the forefront of innovation in the genomics sector. Innovators such as 10x Genomics, Inc. and 23andMe Holding Co. have pioneered platforms that push the boundaries of what is possible in DNA analysis and personalized health insights. Agilent Technologies, Inc. and BGI Genomics Co., Ltd. continue to set high standards in instrument and consumables development, enabling more efficient and expansive analyses. Companies like Bio-Rad Laboratories, Inc. and Centogene N.V. have furthered the field with innovations in assay development and diagnostic capabilities.

Other industry leaders including EPIC Sciences, Inc. and Eurofins Scientific SE underscore the critical role of comprehensive service solutions in driving market adoption. In addition, global entities such as F. Hoffmann-La Roche Ltd. and GE Healthcare (Now Cytiva) by Danaher Corporation have successfully integrated robust R&D with high-quality manufacturing processes, leading to a consistent track record of product reliability. Organizations like Gencove, Inc. and GenScript Biotech Corporation contribute to high-throughput sequencing and gene synthesis respectively, amplifying the reach of genomic technologies.

Leading innovators such as Guardant Health, Inc. and Helix OpCo, LLC have carved niches in clinical diagnostics and data analytics, while renowned firms including Illumina, Inc., Invitae Corporation, and Merck & Co., Inc. continue to lead in research and innovation fronts. The strategic focus of organizations such as Myriad Genetics Laboratories, Inc., Natera, Inc., and Oxford Nanopore Technologies PLC illustrates the sector's ongoing commitment to pushing technological boundaries. An expanding list of influential companies including Pacific Biosciences of California, Inc., Personalis, Inc., and Quest Diagnostics further cement the competitive spirit within this fast-evolving market. The leadership of SomaLogic, Inc., Sophia Genetics SA, Thermo Fisher Scientific Inc., and Twist Bioscience Corporation rounds out a vibrant ecosystem that is continuously reinventing the ways in which genomics is applied for research, diagnostics, and therapeutic innovation.

The collective force of these companies contributes significantly to setting industry standards, driving forward technological innovations, and fostering partnerships that help overcome traditional industry challenges. Their ongoing investment in research and development, global expansion, and commitment to cutting-edge quality and service methodologies ensure that the genomics sector remains dynamic and poised for future growth.

The report delves into recent significant developments in the Genomics Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., 23andMe Holding Co., Agilent Technologies, Inc., BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., Centogene N.V., EPIC Sciences, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., GE Healthcare (Now Cytiva) by Danaher Corporation, Gencove, Inc., GenScript Biotech Corporation, Guardant Health, Inc., Helix OpCo, LLC, Illumina, Inc., Invitae Corporation, Merck & Co., Inc., Myriad Genetics Laboratories, Inc., Natera, Inc., Oxford Nanopore Technologies PLC, Pacific Biosciences of California, Inc., Personalis, Inc., Quest Diagnostics, SomaLogic, Inc., Sophia Genetics SA, Thermo Fisher Scientific Inc., and Twist Bioscience Corporation. Actionable Strategies for Future Industry Success

For industry leaders seeking to secure competitive advantages in the evolving genomics landscape, it is essential to harness technological innovations and streamline operational processes. Prioritizing investments in advanced sequencing technologies, data analytics, and artificial intelligence integration can offer a leap in research capabilities. Leaders are encouraged to foster strategic collaborations that combine academic research with corporate innovation, thereby expanding access to state-of-the-art laboratory facilities and expertise.

Investing in training programs that keep staff updated with the latest technological trends and regulatory updates will further enhance operational efficiency. Integrating flexible business models that can quickly adapt to market trends is equally vital. Moreover, leveraging comprehensive market intelligence and detailed segmentation insights assists in tailoring solutions to meet specific customer requirements while optimizing resource allocation and scaling operations effectively. These proactive initiatives create a robust foundation that not only drives growth but also nurtures innovation in a competitive marketplace.

Final Thoughts on the Genomics Market Evolution

The genomics market continues to demonstrate resilience and adaptability in an era characterized by rapid technological and scientific advancements. A careful analysis of market drivers, segmentation details, and regional variances reveals an industry committed to innovation and sustainability. With a broad spectrum of offerings that range from consumables to sophisticated technologies, the market is well-positioned for sustained growth.

The interplay of collaborative efforts between research institutions, regulatory authorities, and commercial entities paves the way for a future rich in technological breakthroughs and enhanced healthcare outcomes. The continuous evolution of instruments and the diversification of application areas further attest to the sector's dynamic nature. As companies invest in new technologies and embrace cutting-edge analytical methods, the path forward is illuminated by a strategic blend of scientific curiosity and business acumen.

This analysis serves as a robust platform for industry stakeholders looking to understand evolving trends and adapt their strategies accordingly. The careful dissection of market segmentation and the global perspective provided herein underscore the multifaceted opportunities available to those who are agile, forward-thinking, and committed to the pursuit of excellence in genomics.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of genetic disorders globally
    • 5.1.1.2. Growing shift toward precision medicine and personalized therapeutics
    • 5.1.1.3. Expanded application of genomics in agriculture and forensic science
  • 5.1.2. Restraints
    • 5.1.2.1. Concern associated with assessing genetic diversity used in testings
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of AI and advanced bioinformatics for automating and enhancing genomic data analysis
    • 5.1.3.2. Increased funding and grants for research and development in genomics by governments and private organizations
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of standardized methodologies reducing efficiency in the genomics field implementation
• 5.2. Market Segmentation Analysis
  • 5.2.1. Offering: Higher significance of analyzers in genomics for diagnosing and understanding genetic diseases
  • 5.2.2. Technology: Extending applications of CRISPR/Cas9 owing to precision, efficiency, and versatility
  • 5.2.3. Type: Increasing benefits of functional genomics to determine the complex connection between genetic makeup
  • 5.2.4. Applications: Proliferating adoption of genomics in animal genetics for disease resistance and vitality
  • 5.2.5. End Users: Emerging incorporation of genomics by seed companies to develop high-yield crop varieties
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Genomics Market, by Offering

• 6.1. Introduction
• 6.2. Consumables
  • 6.2.1. Kits & Assays
  • 6.2.2. Reagents
• 6.3. Instruments
  • 6.3.1. Analyzers
  • 6.3.2. Sequencers
• 6.4. Service

7. Genomics Market, by Technology

• 7.1. Introduction
• 7.2. Gene Editing Technique
  • 7.2.1. CRISPR/Cas9
  • 7.2.2. TALENs
  • 7.2.3. Zinc Finger Nucleases
• 7.3. Microarray Technology
  • 7.3.1. Cellular Microarray
  • 7.3.2. DNA Microarray
  • 7.3.3. Protein Microarray
• 7.4. PCR Technology
  • 7.4.1. Digital PCR
  • 7.4.2. End-Point PCR
  • 7.4.3. Real-Time PCR
• 7.5. Sequencing Technology
  • 7.5.1. Next-Generation Sequencing
  • 7.5.2. Sanger Sequencing
  • 7.5.3. Third-Generation Sequencing

8. Genomics Market, by Type

• 8.1. Introduction
• 8.2. Epigenomics
• 8.3. Functional Genomics
• 8.4. Pharmacogenomics
• 8.5. Structural Genomics

9. Genomics Market, by Applications

• 9.1. Introduction
• 9.2. Animal Genetics
• 9.3. Crop Development
• 9.4. Diagnostics
• 9.5. Drug Discovery & Development
• 9.6. Personalized Medicine
• 9.7. Research & Development

10. Genomics Market, by End Users

• 10.1. Introduction
• 10.2. Agribusiness
  • 10.2.1. Livestock Companies
  • 10.2.2. Seed Companies
• 10.3. Hospitals & Clinics
• 10.4. Pharmaceutical & Biotechnology Companies
• 10.5. Research Institutes

11. Americas Genomics Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Genomics Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Genomics Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2024
• 14.2. FPNV Positioning Matrix, 2024
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Novo Holdings acquired Benchmark Genetics for strategic growth and innovation
  • 14.3.2. Solis Agrosciences enhances its genomic solutions with the acquisition of Ferris Genomics expertise and platform
  • 14.3.3. Myriad Genetics partners with Ultima Genomics to enhance clinical tests using UG 100 sequencing
  • 14.3.4. Labcorp expands genetic testing capabilities with strategic acquisition of Invitae's advanced assets in oncology and rare diseases
  • 14.3.5. Labcorp and Ultima Genomics partner to develop oncology testing with advanced genomics technologies
  • 14.3.6. Ambry Genetics and PacBio unite to illuminate rare disease origins through sequencing 7,000 genomes
  • 14.3.7. Variantyx accelerates expansion with USD 36 million investment for advanced genomic testing
  • 14.3.8. SOPHiA GENETICS and Strand Life Sciences joined hands to enhance precision medicine
  • 14.3.9. Nucleus Genomics launched the DNA analysis product to increase the accessibility of whole-genome sequencing
  • 14.3.10. Ultima Genomics introduces UG 100 for affordable, accurate sequencing advancements
• 14.4. Strategy Analysis & Recommendation
  • 14.4.1. Agilent Technologies, Inc.
  • 14.4.2. Thermo Fisher Scientific Inc.
  • 14.4.3. Illumina, Inc.
  • 14.4.4. F. Hoffmann-La Roche AG

Companies Mentioned

• 1. 10x Genomics, Inc.
• 2. 23andMe Holding Co.
• 3. Agilent Technologies, Inc.
• 4. BGI Genomics Co., Ltd.
• 5. Bio-Rad Laboratories, Inc.
• 6. Centogene N.V.
• 7. EPIC Sciences, Inc.
• 8. Eurofins Scientific SE
• 9. F. Hoffmann-La Roche Ltd.
• 10. GE Healthcare (Now Cytiva) by Danaher Corporation
• 11. Gencove, Inc.
• 12. GenScript Biotech Corporation
• 13. Guardant Health, Inc.
• 14. Helix OpCo, LLC
• 15. Illumina, Inc.
• 16. Invitae Corporation
• 17. Merck & Co., Inc.
• 18. Myriad Genetics Laboratories, Inc.
• 19. Natera, Inc.
• 20. Oxford Nanopore Technologies PLC
• 21. Pacific Biosciences of California, Inc.
• 22. Personalis, Inc.
• 23. Quest Diagnostics
• 24. SomaLogic, Inc.
• 25. Sophia Genetics SA
• 26. Thermo Fisher Scientific Inc.
• 27. Twist Bioscience Corporation